Scholarly Index

David A. Reardon

Dana-Farber Cancer Institute; 61,849 total citations; 883 total publications; best world rank #7

Dana-Farber Cancer Institute

61,849Total citations

883Total publications

119H-index

Published ranking records

Field	Window	World rank	National rank	Impact score
Medical Genetics	Lifetime	12	US 7	99.89
Oncology	Lifetime	551	US 304	98.97
Cancer Research	Lifetime	620	US 328	95.79
Medical Genetics	2021-2025	17	US 10	99.57
Oncology	2021-2025	428	US 190	94.88
Immunology	2021-2025	488	US 179	86.55
Cancer Research	2021-2025	386	US 150	73.64
Brain Metastases and Treatment	Lifetime	7	US 4	99.88
Glioma Diagnosis and Treatment	Lifetime	12	US 8	99.93
Cancer, Hypoxia, and Metabolism	Lifetime	60	US 31	99.72
Cancer Immunotherapy and Biomarkers	Lifetime	59	US 35	99.82
Neuroblastoma Research and Treatments	Lifetime	45	US 28	99.50
Cancer Research and Treatments	Lifetime	73	US 50	99.33
Radiomics and Machine Learning in Medical Imaging	Lifetime	139	US 61	99.39
Histone Deacetylase Inhibitors Research	Lifetime	77	US 55	99.17
CAR-T cell therapy research	Lifetime	280	US 172	99.10
Immunotherapy and Immune Responses	Lifetime	738	US 388	98.86
Meningioma and schwannoma management	Lifetime	224	US 136	98.68
Cancer Treatment and Pharmacology	Lifetime	524	US 263	98.55
Cancer Genomics and Diagnostics	Lifetime	990	US 503	98.28
Angiogenesis and VEGF in Cancer	Lifetime	393	US 180	97.57
Nanoplatforms for cancer theranostics	Lifetime	823	US 116	97.39
Cancer Mechanisms and Therapy	Lifetime	331	US 154	96.58
Protein Degradation and Inhibitors	Lifetime	560	US 281	96.08
Radiopharmaceutical Chemistry and Applications	Lifetime	878	US 349	96.28
Cancer therapeutics and mechanisms	Lifetime	939	US 458	95.69
Neurofibromatosis and Schwannoma Cases	Lifetime	592	US 311	94.58
Cancer-related cognitive impairment studies	Lifetime	898	US 456	84.77
Glioma Diagnosis and Treatment	2021-2025	7	US 3	99.85
Brain Metastases and Treatment	2021-2025	22	US 11	99.06
Cancer Immunotherapy and Biomarkers	2021-2025	194	US 78	99.27
Immunotherapy and Immune Responses	2021-2025	160	US 57	97.54
CAR-T cell therapy research	2021-2025	428	US 240	97.30
Cancer Research and Treatments	2021-2025	120	US 35	93.51
Immune cells in cancer	2021-2025	767	US 165	89.46
Neuroblastoma Research and Treatments	2021-2025	594	US 221	86.90
Meningioma and schwannoma management	2021-2025	726	US 257	86.74
Fibroblast Growth Factor Research	2021-2025	295	US 94	76.10